Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis.
about
Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials.Gender based differences in drug eluting stent implantation - data from the German ALKK registry suggest underuse of DES in elderly women.A scoping review of indirect comparison methods and applications using individual patient dataCardiac Evaluation and Monitoring of Patients Undergoing Noncardiac Surgery.ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathyLong-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting.Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials.Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.Continuation of Dual-Antiplatelet Therapy Following Percutaneous Revascularization with a Drug-Eluting Stent: What Duration Is Optimal?Drug-eluting stents to prevent stent thrombosis and restenosis.The year in cardiology 2015: coronary intervention.Optimal duration of dual antiplatelet therapy following percutaneous coronary intervention: protocol for an umbrella review.Dual antiplatelet therapy after coronary stenting.Safety and efficacy of 6-month versus 12-month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer-coated sirolimus-eluting coronary stents: Insight from the I-LOVE-IT 2 trial.Dual antiplatelet therapy and non-cardiac surgery: evolving issues and anesthetic implications.Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study.Short-versus long-term Dual Antiplatelet therapy after drug-eluting stent implantation in women versus men: A sex-specific patient-level pooled-analysis of six randomized trials.Comparison of mid-term outcomes between patients with and without atrial fibrillation undergoing coronary stenting in the second-generation drug-eluting stent era: from the SHINANO registry.Impact of six versus 12 months of dual antiplatelet therapy in patients with drug-eluting stent implantation after risk stratification with the residual SYNTAX score: Results from a secondary analysis of the I-LOVE-IT 2 trial.Early healing assessment with optical coherence tomography of everolimus-eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation.Clinical outcomes of dual antiplatelet therapy after implantation of drug-eluting stents in patients with different cardiovascular risk factors.Drug-Coated Balloons: A Safe and Effective Alternative to Drug-Eluting Stents in Small Vessel Coronary Artery Disease.Dual antiplatelet therapy duration after drug-eluting stents: how long?Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial.Duration of dual antiplatelet therapy after drug-eluting stent implantation: Meta-analysis of large randomised controlled trials.Non-cardiac surgery following drug-eluting coronary stent implantation-a question of timing?Duration of dual antiplatelet therapy (DAPT): a call for personalized medicine.Dual antiplatelet therapy for secondary prevention of coronary artery disease.Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.Optimal duration of dual antiplatelet therapy after drug eluting stent implantation: a network meta-analysis.Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients.Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.Penetration rate of the placement of a drug-eluting stent for the treatment of superficial femoral artery lesions in Japan.Optimal antiplatelet strategy after transcatheter aortic valve implantation: a meta-analysis.Early vascular responses after everolimus-eluting stent implantation assessed by serial observations of intracoronary optical coherence tomography.Viewpoint: a proposal for a simple algorithm for managing oral anticoagulation and antiplatelet therapy in patients with non-valvular atrial fibrillation and coronary stents.Antiplatelet Therapy for Non-ST-Segment Elevation Myocardial Infarction in Complex "Real" Clinical Scenarios: A Consensus Document of the "Campania NSTEMI Study Group".Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Which Regimen and for How Long?Antiplatelet therapy: Defining the optimal duration of DAPT after PCI with DES.Efficacy and safety of prolonged dual antiplatelet therapy: a meta-analysis of 15 randomized trials enrolling 85 265 patients.
P2860
Q30241829-BB7D4E20-B8CC-4B28-9123-25C66B639759Q30313391-61C4B1C3-E763-4B64-9724-551B66636C0CQ31085484-15124ED7-911B-4A74-B671-5B0A95703612Q33583698-7378F898-0B97-44B0-AFAC-C7BEF0572D9FQ33647497-3613930E-C96B-43EA-8E57-9AA0CC6B72BAQ36081846-AE608EE7-7599-4230-8147-DE041A095954Q38526074-09A6AC58-255C-44A2-AA92-F939BD3D5E58Q38577755-D12011C1-0889-4161-B556-A112332623E8Q38591868-8A6C6F4E-A06B-4894-A783-6A64A6878423Q38633332-1C32402B-AFAA-4B7F-A593-509AEB368AA4Q38685684-EA7941D1-02EB-4513-9E74-C0287E24FBA7Q38854639-7D6A4BAD-E34E-4DBD-93DD-128906419924Q38866836-AAEDC442-0481-4B32-99B8-79820B23BBF5Q38894581-EB8124CE-7DDF-48AA-B1CA-B51EFC90960DQ39129014-E4F832CE-0A5E-4AC7-93F0-312893EB614FQ39288609-6FFD0015-187A-4213-AE1A-CB80AD469B37Q39592831-C379A834-A713-4B9F-9A07-89711385A07CQ39677417-96196E2F-2225-4496-998C-DEFA89B1A777Q40330517-86906693-C1B5-4CD9-999A-E309425A2624Q40364494-F45A41CA-F91A-49D2-9645-DBBA506BCBEBQ40580110-41B4893B-7AD0-4956-9784-064B4895A124Q40600768-02680CDD-867A-41BB-9A9F-559C914224B1Q41111747-7F70C335-67ED-435A-A8A4-B65AC53B4012Q41367415-09AD371D-788B-4100-9983-658248666288Q41960465-AD19C07F-FA7A-4AC9-99FC-7849ADDBD52DQ42340613-DD650FCE-AD09-4B61-ACDF-71D948FA500DQ42369292-180D5DEC-C2BC-4EC1-8F56-A1ACC9036CC7Q42650020-73775AAF-8164-491E-A683-4292B24D1471Q44888352-4B1C3EE5-C0CB-4B61-9120-D6435AD2687DQ47136631-FE4B9744-C6FA-4160-B587-D22652BEE7FEQ47654430-42A2B771-9568-4CE8-840D-A41A850AA316Q47657861-D1B93130-61AC-4634-929D-1224941515CFQ47779815-B011CB50-AC51-4C86-A735-CC3DF6776B32Q48509208-D7B5541C-250C-4BDF-A75F-393EC89671D3Q50216134-BA3768E0-BD32-4E7C-97BA-92AC23BA190AQ50793412-77B79651-57AE-45BB-B559-4C4415DE8A23Q50864337-2E0BEFDE-ADBC-4D2B-AAC7-0EA7CAD79031Q53200993-989001B1-FAC9-451F-A702-A6E25719C2B7Q53213605-4819E180-32A0-40F2-BF31-B5125614784EQ53581195-FFA9BF11-69E2-4198-B9E0-E26FC088A6A9
P2860
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Short- versus long-term dual a ...... ise and network meta-analysis.
@ast
Short- versus long-term dual a ...... ise and network meta-analysis.
@en
type
label
Short- versus long-term dual a ...... ise and network meta-analysis.
@ast
Short- versus long-term dual a ...... ise and network meta-analysis.
@en
prefLabel
Short- versus long-term dual a ...... ise and network meta-analysis.
@ast
Short- versus long-term dual a ...... ise and network meta-analysis.
@en
P2093
P50
P1476
Short- versus long-term dual a ...... ise and network meta-analysis.
@en
P2093
Alexandre Abizaid
Andrea Mariani
Deepak L Bhatt
Diego Della Riva
Diego Sangiorgi
Fausto Feres
Gregg W Stone
Hyo-Soo Kim
Kyung Woo Park
Martin B Leon
P304
P356
10.1016/J.JACC.2014.12.046
P407
P577
2015-03-01T00:00:00Z